Viewing StudyNCT04433156



Ignite Creation Date: 2024-05-06 @ 2:48 PM
Last Modification Date: 2024-10-26 @ 1:37 PM
Study NCT ID: NCT04433156
Status: RECRUITING
Last Update Posted: 2023-05-18
First Post: 2020-06-11

Brief Title: VR-CAP in the First-line Treatment for Patients With Marginal Zone Lymphoma
Sponsor: Henan Cancer Hospital
Organization: Henan Cancer Hospital

Conditions & Keywords Data

Conditions:
Name
Marginal Zone Lymphoma
Keywords:
Name View
Marginal Zone Lymphoma View
VR-CAP View